Australia · 
Who invested in Kira Biotech?
Kira Biotech's investors include OneVentures, IP Group and Advance Queensland Business Development Fund. OneVentures led its latest round.
Australia · Series A startup
Who invested in Kira Biotech
Funding summaryUpdated 26 Oct 2026
$20Mraised across 1 round since 2019, from 2 sources
- Latest round
- Series A, $20MOct 2019
- Led by
- OneVentures
- Investors
- 3 (1 led)
The rounds
- Oct 2019Series A$20M
OneVenturesLead
IP Group- Advance Queensland Business Development Fund
Reported by Ipgroupanz and 1 other
Founders and team
From Kira Biotech's own website: 6 on the team.
- Dan BakerCEO and Director
- James UpdikeChief Business Officer
- Georgina ClarkDirector & Scientist
- Michael GrissingerBoard Chair
- Sarah MeibuschDirector
- Siro PerezDirector
Everyone who backed them
Advance Queensland Business Development Fundno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Kira Biotech as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Kira Biotech
How much has Kira Biotech raised?
Kira Biotech has raised $20M across 1 round since 2019.
When did Kira Biotech last raise?
Kira Biotech's most recent round was a Series A of $20M in Oct 2019, led by OneVentures.
What was Kira Biotech's biggest round?
Its most recent round, $20M in Oct 2019, is also its largest on record.
Who backed Kira Biotech first?
Kira Biotech's first round on record, in Oct 2019, was backed by OneVentures, IP Group and Advance Queensland Business Development Fund.
What stage is Kira Biotech at?
Kira Biotech's latest named round is a Series A, in Oct 2019.
Where is Kira Biotech based?
Kira Biotech is based in Australia.
Who led Kira Biotech's rounds?
OneVentures led the Series A in 2019.
Companies like Kira Biotech
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.